118 related articles for article (PubMed ID: 38286142)
1. Masculine enhancement as health or pathology: gender and optimisation discourses in health promotion materials on performance and image-enhancing drugs (PIEDs).
Nourse G; Fraser S; Moore D
Health Sociol Rev; 2024 Jan; ():1-17. PubMed ID: 38286142
[TBL] [Abstract][Full Text] [Related]
2. Masculinities, practices and meanings: A critical analysis of recent literature on the use of performance- and image-enhancing drugs among men.
Moore D; Hart A; Fraser S; Seear K
Health (London); 2020 Nov; 24(6):719-736. PubMed ID: 30922123
[TBL] [Abstract][Full Text] [Related]
3. Men, bodywork, health and the potentiality of performance and image-enhancing drugs.
Dowsett GW; Duncan D; Waling A; Angelides S; Nourse G
Health Sociol Rev; 2023 Nov; 32(3):341-356. PubMed ID: 36577038
[TBL] [Abstract][Full Text] [Related]
4. Maintaining the healthy body: Blood management and hepatitis C prevention among men who inject performance and image-enhancing drugs.
Fomiatti R; Lenton E; Latham JR; Fraser S; Moore D; Seear K; Aitken C
Int J Drug Policy; 2020 Jan; 75():102592. PubMed ID: 31855731
[TBL] [Abstract][Full Text] [Related]
5. Consumption in contrast: The politics of comparison in healthcare practitioners' accounts of men who inject performance and image-enhancing drugs.
Seear K; Moore D; Fraser S; Fomiatti R; Aitken C
Int J Drug Policy; 2020 Nov; 85():102883. PubMed ID: 32798925
[TBL] [Abstract][Full Text] [Related]
6. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
Larance B; Degenhardt L; Copeland J; Dillon P
Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
[TBL] [Abstract][Full Text] [Related]
7. Is another relationship possible? Connoisseurship and the doctor-patient relationship for men who consume performance and image-enhancing drugs.
Fraser S; Fomiatti R; Moore D; Seear K; Aitken C
Soc Sci Med; 2020 Feb; 246():112720. PubMed ID: 31972378
[TBL] [Abstract][Full Text] [Related]
8. Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia.
Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L
Subst Abus; 2020; 41(1):139-145. PubMed ID: 31545138
[No Abstract] [Full Text] [Related]
9. Across the spectrum of legality: The market activities of influencers specialized in steroids and other performance and image enhancing drugs.
Paoli L; Joseph Cox LT
Int J Drug Policy; 2024 Jan; 123():104246. PubMed ID: 37979285
[TBL] [Abstract][Full Text] [Related]
10. Performance and image enhancing drug interventions aimed at increasing knowledge among healthcare professionals (HCP): reflections on the implementation of the Dopinglinkki e-module in Europe and Australia in the HCP workforce.
Atkinson AM; van de Ven K; Cunningham M; de Zeeuw T; Hibbert E; Forlini C; Barkoukis V; Sumnall HR
Int J Drug Policy; 2021 Sep; 95():103141. PubMed ID: 33549466
[TBL] [Abstract][Full Text] [Related]
11. Social suppliers: Exploring the cultural contours of the performance and image enhancing drug (PIED) market among bodybuilders in the Netherlands and Belgium.
van de Ven K; Mulrooney KJ
Int J Drug Policy; 2017 Feb; 40():6-15. PubMed ID: 27574781
[TBL] [Abstract][Full Text] [Related]
12. Performance and image enhancing drug injectors' access to needle syringe programs: Responding to a public policy dilemma.
van Beek I; Chronister KJ
Int J Drug Policy; 2015 Sep; 26(9):868-74. PubMed ID: 26118797
[TBL] [Abstract][Full Text] [Related]
13. An overview on performance and image enhancing drugs (PIEDs) confiscated in Italy in the period 2017-2019.
Odoardi S; Mestria S; Biosa G; Valentini V; Federici S; Strano Rossi S
Clin Toxicol (Phila); 2021 Jan; 59(1):47-52. PubMed ID: 32475176
[TBL] [Abstract][Full Text] [Related]
14. 'We don't tell people what to do': ethical practice and Indigenous health promotion.
McPhail-Bell K; Bond C; Brough M; Fredericks B
Health Promot J Austr; 2015 Dec; 26(3):195-199. PubMed ID: 26599355
[TBL] [Abstract][Full Text] [Related]
15. The Liver King Lie: Misrepresentation, justification, and public health implications.
Gibbs N; Piatkowski T
Int J Drug Policy; 2023 Apr; 114():103979. PubMed ID: 36841216
[TBL] [Abstract][Full Text] [Related]
16. Investigating the impact of COVID-19 on performance and image enhancing drug use.
Dunn M; Piatkowski T
Harm Reduct J; 2021 Dec; 18(1):124. PubMed ID: 34863199
[TBL] [Abstract][Full Text] [Related]
17. Discourses of masculinity, femininity and sexuality in Uganda's Stand Proud, Get Circumcised campaign.
Rudrum S; Oliffe JL; Benoit C
Cult Health Sex; 2017 Feb; 19(2):225-239. PubMed ID: 27684495
[TBL] [Abstract][Full Text] [Related]
18. The use of supplements and performance and image enhancing drugs in fitness settings: A exploratory cross-sectional investigation in the United Kingdom.
Mooney R; Simonato P; Ruparelia R; Roman-Urrestarazu A; Martinotti G; Corazza O
Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657184
[TBL] [Abstract][Full Text] [Related]
19. The diffusion of performance and image-enhancing drugs (PIEDs) on the internet: the abuse of the cognitive enhancer piracetam.
Corazza O; Bersani FS; Brunoro R; Valeriani G; Martinotti G; Schifano F
Subst Use Misuse; 2014 Dec; 49(14):1849-56. PubMed ID: 24827869
[TBL] [Abstract][Full Text] [Related]
20. Body Image and Eating Disorders are Common among Professional and Amateur Athletes Using Performance and Image Enhancing Drugs: A Cross-Sectional Study.
Piacentino D; Kotzalidis GD; Longo L; Pavan A; Stivali L; Stivali G; Ferracuti S; Brugnoli R; Frati P; Fineschi V; Girardi P; Sani G
J Psychoactive Drugs; 2017; 49(5):373-384. PubMed ID: 28777732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
